189 related articles for article (PubMed ID: 26400025)
1. Simultaneous measurement of serum chemokines in autoimmune thyroid diseases: possible role of IP-10 in the inflammatory response.
Hiratsuka I; Itoh M; Yamada H; Yamamoto K; Tomatsu E; Makino M; Hashimoto S; Suzuki A
Endocr J; 2015; 62(12):1059-66. PubMed ID: 26400025
[TBL] [Abstract][Full Text] [Related]
2. Circulating chemokines in patients with autoimmune thyroid diseases.
Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
[TBL] [Abstract][Full Text] [Related]
3. Serum CXCL10 levels and neuromuscular manifestations in patients with autoimmune thyroid diseases.
Cakir M; Levendoglu F; Kiyici A; Coskun Y
Autoimmunity; 2011 Sep; 44(6):496-503. PubMed ID: 21457060
[TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum IL-16 and RANTES levels in patients with autoimmune thyroid diseases and modulation by methimazole therapy.
Gu X; Zheng L; Chen X; Ruan L; Zhang H; Ge S; Zhu H; Lin X; Shen F
Horm Metab Res; 2012 Jun; 44(6):482-7. PubMed ID: 22473756
[TBL] [Abstract][Full Text] [Related]
6. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease].
Zhang JA; Zhang J; Xu L; Mar H; Wu XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):630-2. PubMed ID: 16948912
[TBL] [Abstract][Full Text] [Related]
8. Different levels of circulating Th22 cell and its related molecules in Graves' disease and Hashimoto's thyroiditis.
Song RH; Yu ZY; Qin Q; Wang X; Muhali FS; Shi LF; Jiang WJ; Xiao L; Li DF; Zhang JA
Int J Clin Exp Pathol; 2014; 7(7):4024-31. PubMed ID: 25120780
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs in autoimmune thyroid diseases.
Yamada H; Itoh M; Hiratsuka I; Hashimoto S
Clin Endocrinol (Oxf); 2014 Aug; 81(2):276-81. PubMed ID: 24533739
[TBL] [Abstract][Full Text] [Related]
11. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
[TBL] [Abstract][Full Text] [Related]
12. Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.
Antonelli A; Rotondi M; Fallahi P; Romagnani P; Ferrari SM; Barani L; Ferrannini E; Serio M
Clin Endocrinol (Oxf); 2006 Feb; 64(2):189-95. PubMed ID: 16430719
[TBL] [Abstract][Full Text] [Related]
13. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
Myśliwiec J; Okota M; Nikołajuk A; Górska M
Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
[TBL] [Abstract][Full Text] [Related]
14. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Romagnani P; Grosso M; Ferrannini E; Serio M
Eur J Endocrinol; 2006 May; 154(5):651-8. PubMed ID: 16645011
[TBL] [Abstract][Full Text] [Related]
15. Increased differentiation of Th22 cells in Hashimoto's thyroiditis.
Bai X; Sun J; Wang W; Shan Z; Zheng H; Li Y; Zhao Y; Gong M; Teng W
Endocr J; 2014; 61(12):1181-90. PubMed ID: 25242258
[TBL] [Abstract][Full Text] [Related]
16. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
[TBL] [Abstract][Full Text] [Related]
17. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
[TBL] [Abstract][Full Text] [Related]
18. Elevated interleukin-1β in peripheral blood mononuclear cells contributes to the pathogenesis of autoimmune thyroid diseases, especially of Hashimoto thyroiditis.
Sun L; Zhang X; Dai F; Shen J; Ren C; Zuo C; Zhang Q
Endocr Res; 2016 Aug; 41(3):185-92. PubMed ID: 26864865
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
20. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]